tetano
Editor, Senior Moderator
Signal Transduct Target Ther
. 2023 Dec 21;8(1):466.
doi: 10.1038/s41392-023-01724-w. Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period
Danyi Ao[SUP] #[/SUP][SUP] 1 [/SUP], Xuemei He[SUP] #[/SUP][SUP] 1 [/SUP], Jian Liu[SUP] 1 [/SUP], Li Xu[SUP] 2 [/SUP]
Affiliations
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in significant casualties and put immense strain on public health systems worldwide, leading to economic recession and social unrest. In response, various prevention and control strategies have been implemented globally, including vaccine and drug development and the promotion of preventive measures. Implementing these strategies has effectively curbed the transmission of the virus, reduced infection rates, and gradually restored normal social and economic activities. However, the mutations of SARS-CoV-2 have led to inevitable infections and reinfections, and the number of deaths continues to rise. Therefore, there is still a need to improve existing prevention and control strategies, mainly focusing on developing novel vaccines and drugs, expediting medical authorization processes, and keeping epidemic surveillance. These measures are crucial to combat the Coronavirus disease (COVID-19) pandemic and achieve sustained, long-term prevention, management, and disease control. Here, we summarized the characteristics of existing COVID-19 vaccines and drugs and suggested potential future directions for their development. Furthermore, we discussed the COVID-19-related policies implemented over the past years and presented some strategies for the future.
. 2023 Dec 21;8(1):466.
doi: 10.1038/s41392-023-01724-w. Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period
Danyi Ao[SUP] #[/SUP][SUP] 1 [/SUP], Xuemei He[SUP] #[/SUP][SUP] 1 [/SUP], Jian Liu[SUP] 1 [/SUP], Li Xu[SUP] 2 [/SUP]
Affiliations
- PMID: 38129394
- DOI: 10.1038/s41392-023-01724-w
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in significant casualties and put immense strain on public health systems worldwide, leading to economic recession and social unrest. In response, various prevention and control strategies have been implemented globally, including vaccine and drug development and the promotion of preventive measures. Implementing these strategies has effectively curbed the transmission of the virus, reduced infection rates, and gradually restored normal social and economic activities. However, the mutations of SARS-CoV-2 have led to inevitable infections and reinfections, and the number of deaths continues to rise. Therefore, there is still a need to improve existing prevention and control strategies, mainly focusing on developing novel vaccines and drugs, expediting medical authorization processes, and keeping epidemic surveillance. These measures are crucial to combat the Coronavirus disease (COVID-19) pandemic and achieve sustained, long-term prevention, management, and disease control. Here, we summarized the characteristics of existing COVID-19 vaccines and drugs and suggested potential future directions for their development. Furthermore, we discussed the COVID-19-related policies implemented over the past years and presented some strategies for the future.